PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 207 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $8,059,000 | +1486.4% | 447,963 | +528.9% | 0.04% | +1266.7% |
| Q1 2020 | $508,000 | -64.5% | 71,230 | +35.3% | 0.00% | -40.0% |
| Q2 2019 | $1,429,000 | -60.5% | 52,653 | -49.5% | 0.01% | -64.3% |
| Q1 2019 | $3,615,000 | +368.3% | 104,190 | +163.5% | 0.01% | +366.7% |
| Q4 2018 | $772,000 | +38.8% | 39,536 | +89.2% | 0.00% | +50.0% |
| Q3 2018 | $556,000 | -82.8% | 20,891 | -75.5% | 0.00% | -84.6% |
| Q2 2018 | $3,224,000 | – | 85,368 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |